Expertise in
3
conditions

Nikolaj Frost

Berlin, BE, DE 
Expertise in
3
conditions
Berlin, BE, DE 

Overview

Nikolaj Frost practices practicing medicine in Berlin, Germany.

Mr. Frost is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Febrile Neutropenia.

He is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Berlin, BE, Germany
Other Locations
Koeln, NW, Germany
Mitte, BE 10117, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Advancing Brigatinib Properties in Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer (ALK+ NSCLC) Patients
Advancing Brigatinib Properties in Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer (ALK+ NSCLC) Patients
Enrollment Status: Completed
Publish Date: June 23, 2026
Intervention Type: Drug
Study Drugs: Brigatinib, Tyrosine kinase inhibitor
Study Phase: Phase 2
Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients
Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: X-396 (Ensartinib), Crizotinib
Study Phase: Phase 3
View 1 Less Clinical Trial

76 Total Publications

Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.
Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.
Journal: The Lancet. Respiratory medicine
Published: May 09, 2026

Frequently Asked Questions about Nikolaj Frost

Is Nikolaj Frost a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Nikolaj Frost is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nikolaj Frost participate in research or clinical trials?

Yes. Nikolaj Frost has published 76 articles and abstracts on conditions like Lung Cancer. You can view a list of Nikolaj Frost's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Frost's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile